%0 Journal Article
%T Fibronectin Binding Is Required for Acquisition of Mesenchymal/Endothelial Differentiation Potential in Human Circulating Monocytes
%A Noriyuki Seta
%A Yuka Okazaki
%A Keisuke Izumi
%A Hiroshi Miyazaki
%A Takashi Kato
%A Masataka Kuwana
%J Journal of Immunology Research
%D 2012
%R 10.1155/2012/820827
%X We previously reported monocyte-derived multipotential cells (MOMCs), which include progenitors capable of differentiating into a variety of mesenchymal cells and endothelial cells. In vitro generation of MOMCs from circulating CD14+ monocytes requires their binding to extracellular matrix (ECM) protein and exposure to soluble factor(s) derived from circulating CD14- cells. Here, we investigated the molecular factors involved in MOMC generation by examining the binding of monocytes to ECM proteins. We found that MOMCs were obtained on the fibronectin, but not on type I collagen, laminin, or poly-L-lysine. MOMC generation was followed by changes in the expression profiles of transcription factors and was completely inhibited by either anti-¦Á5 integrin antibody or a synthetic peptide that competed with the RGD domain for the ¦Â1-integrin binding site. These results indicate that acquisition of the multidifferentiation potential by circulating monocytes depends on their binding to the RGD domain of fibronectin via cell-surface ¦Á5¦Â1 integrin. 1. Introduction Circulating CD14+ monocytes originate from hematopoietic stem cells in the bone marrow and are heterogeneous in terms of their surface markers, phagocytic capacity, and differentiation potentials [1]. Until recently, it was believed that the differentiation potential of monocytes was restricted to cells that function as phagocytes and/or antigen-presenting cells, including macrophages, dendritic cells, and osteoclasts, but recent accumulating evidence indicates that circulating monocytes have the potential to differentiate into a variety of cell types other than phagocytes [2¨C6]. We recently identified a peripheral blood-derived cell population that has a fibroblast-like morphology in culture and a unique phenotype positive for CD14, CD45, CD34, and type I collagen (collagen (I)) [7]. These cells originate from circulating CD14+ monocytes and include primitive cells that can differentiate into cells with morphologic, phenotypic, and functional features of several distinct mesenchymal cell types, including bone, cartilage, fat, and skeletal and cardiac muscle, as well as neurons and endothelium; thus, they are termed monocyte-derived multipotential cells (MOMCs) [7¨C10]. It is thus plausible that circulating monocytes are involved in tissue remodelling and regeneration through MOMC differentiation under physiologic and pathogenic conditions in vivo. MOMCs are obtained in 7-day cultures of peripheral blood mononuclear cells (PBMCs) on fibronectin-coated plastic plates with 10% fetal bovine serum (FBS) as
%U http://www.hindawi.com/journals/jir/2012/820827/